Mixed SERM/SERDs (the so-called SERM/SERD hybrids) such as lasofoxifene (laso) [222] and bazedoxifene [223,224] have been proposed as a potential treatment of ER-positive metastatic BC. Here, ESR1 is linked to breast cancer.